Small-cell lung cancer (SCLC) lines are distinguished from non-small-cell lung cancer (NSCLC) lines by their growth in floating aggregates, in contrast to the adherent monolayers formed by NSCLC cells in culture. Of 50 well-characterized SCLC lines recently described by the National Cancer Institute (NCI)-Navy Medical Oncology Branch, only four variant cell lines (SCLC-v) grew as adherent monolayers. One line, NCI-H446, was unique in growing long-term with coexisting floating and surface adherent subpopulations. We have physically segregated these two populations over many passages in vitro to enrich for relatively pure cultures of floating and adherent cells. No differences in c-myc expression, keratin pattern, or cytogenetic appearance were found between the adherent and floating sublines. However, expression of the neuroendocrine marker neuron-specific enolase in the floating cells was three times that found in the adherent cells. The floating subline also had much greater surface expression of neuroendocrine tumor antigens detected by monoclonal antibodies UJ13A and HNK-1, which have been recently shown to detect the neural cell adhesion molecule (NCAM) on SCLC cells. Two other adherent SCLC-v lines were also found to be unreactive with UJ13A and HNK-1, generalizing the association between NCAM expression and the growth of most SCLC cultures as floating aggregates. In conclusion, we have an interesting model to study expression of NCAM as related to the adhesive properties of SCLC cells. (J. Clin. Invest. 1990Invest. . 86:1848Invest. -1854 Key words: lung cancer * neural cell adhesion molecule * neuron-specific enolase Introduction A striking difference between small-cell lung cancer (SCLC)'
Introduction
A striking difference between small-cell lung cancer (SCLC)' and non-small-cell lung cancer (NSCLC) cells in vitro is that 1 . Abbreviations used in this paper: NCAM, neural cell adhesion molecule; NCI, National Cancer Institute; NSCLC, non-small-cell lung cancer; NSE, neuron-specific enolase; SCLC and SCLC-v, small-cell lung cancer and variant SCLC; SC-1, SCLC cluster 1.
SCLC cells generally float in spheroid aggregates and NSCLC cells grow as adherent monolayers (1) . Classic SCLC cells tend to grow in tight spheroids with central necrosis whereas variant SCLC cells (SCLC-v) grow in looser branching chains (2) . A small number of SCLC-v lines have been noted to grow in adherent monolayers in vitro (3) . These adherent variant cells, referred to as having type 4 morphology, are clearly SCLC by other morphologic, cytogenetic, and biochemical features. In the experience of the National Cancer Institute (NCI)-Navy Medical Oncology Branch, only one well-characterized line has been described as growing with coexisting adherent and floating subpopulations, although similar lines have been described in the literature (3) . This line, NCI-H446, was derived from the pleural effusion of a SCLC patient and expresses the SCLC biochemical markers neuron-specific enolase (NSE) and the brain isoenzyme of creatine kinase (4, 5) . cells form tumors with SCLC-v morphology (3) , when im- planted in nude mice.
The adherent NCI-H446 cells, although distinct from NSCLC cells by electron microscopy, mimic the culture properties of NSCLC (3) . We were interested in whether the adherent SCLC cells had lost any ofthe neuroendocrine or immunologic markers distinguishing SCLC from NSCLC. By developing floating and surface adherent sublines of the NCI-H446 line, we were able to directly examine the association ofgrowth as an adherent monolayer on several characteristic amine precursor uptake and decarboxylation or neuroendocrine properties of SCLC cells.
Moolenaar et al. (6) and Kibbelaar et al. (7) have recently demonstrated that a dominant surface antigen of SCLC cells, recognized by numerous monoclonal antibodies (MAbs) and termed SCLC cluster 1 (SC-1), is actually a neural cell adhesion molecule (NCAM)-related sialoglycoprotein. We have been able to use our adherent and floating sublines of H446 to examine expression of NCAM determinants as related to the adherent properties of SCLC cells.
Methods
Cell cultures. We used the previously described human SCLC-v cell line NCI-H446, derived from the pleural effusion of a patient who had relapsed with disease after treatment with combination chemotherapy (3) . Like most SCLC-v lines, H446 cells do not express L-dopa decarboxylase or bombesin-like immunoreactivity (8) . The classic SCLC lines H209 and H146, the SCLC-v line N417 and the NSCLC lines HI 57, H125, and H522 were used for comparative studies and have been previously described (9) . Two unusual SCLC lines, H1607 and H196-B, which form adherent monolayers in vitro, were also used. These two cell lines, characterized as having type 4 SCLC morphology, were derived from patients with SCLC histology (3) . H 196-B has been further characterized, and forms typical SCLC tumors of an intermediate type when inoculated into nude mice, as well as having detectable SCLC markers of NSE and creatine kinase (3) . All cell lines were tested and found to be free of Mycoplasma contamination.
Culture conditions and experimental protocols were as previously described (3) . NSCLC cells were maintained in RPMI-1640 in the presence of 10%1 fetal bovine serum and 2 mM L-glutamine. The SCLC cells were grown in 2% fetal bovine serum with the addition of hydrocortisone, insulin, transferrin, estradiol, and selenium reagents as previously described (10 (12) . HNK-l has been shown to react with NCAM (13) . W6/32 reacts with the HLA-A,B,C heavy chain and BBM. 1 reacts with #2-microglobulin (14) . These three MAbs antibodies were obtained from the American Type Culture Collection, Rockville, MD. A rabbit antisera (Dako Corp., Santa Barbara, CA) specific for human (2-microglobulin was also used. Antibodies AE-1, AE-2, and AE-3 were obtained from Dr. Tien-Treen Sun, New York University School of Medicine. AE-l reacts against most acidic keratins and AE-3 reacts with all eight of the basic keratin species (15) . AE-2 reacts with a 56,000-mol wt acidic keratin and 65,000-and 68,000 mol wt basic keratin species (15) . Murine IgGl MAbs UJ13A and AUA1 are reactive with SCLC cluster antigens 1 and 2, respectively, and were obtained from Dr. Robert Souhami, Courtauld Institute ofBiochemistry, London, England (16) . The cluster 1 antigen has been determined to be NCAM (6) . Melanoma tumors and cell lines are only weakly stained by the cluster 2 antibody AUA1 and neuroblastoma is negative, but carcinoid tumors and cell lines are positive, showing, like SCLC, a mixture of neural and epithelial markers (16) . A cDNA corresponding to this protein has been recently cloned and sequenced, revealing a transmembrane domain and several potential N-glycosylation sites (17) . Murine IgG MAbs SWA22 and SWA20 react with SCLC cluster antigens 4 and 5, respectively, and were provided by Dr. Robert Waibel, University Hospital, Zurich, Switzerland (18) .
Radioimmunoassay. The radiobinding assays were performed in 96-well polyvinyl-chloride microtiter plates (Costar Data Packaging, Cambridge, MA) as previously described (9) . Adherent The plates were incubated with S Ag/ml concentrations of primary antibody for 1 h, followed by incubation with a 1:100 dilution of affinity-purified rabbit anti-mouse Ig hyperimmune serum for 1 h (Jackson Research Laboratories, Bar Harbor, ME). All incubations were in PBS at room temperature. The detecting reagent was 40,000 cpm/25 Ml of '25l-labeled protein A (New England Nuclear, Boston, MA). Purified mouse myeloma IgG2a (RPC5, Litton Bionetics, Inc., Kensington, MD) was used as a negative control. Counting was performed on a Gamma 4000 counter (Beckman Instruments, Inc., Palo Alto, CA).
Analysis of indirect immunofluorescence byflow cytometry. Adherent cells were harvested by scraping and single-cell suspensions were made by trituration through a 21-gauge needle. After PBS washings, log-phase cultures of SCLC were incubated under saturation conditions with 1:100 to 1:500 dilutions of the protein A purified (2 mg/ml) antibodies. The total reaction volume was 0.2 ml. After incubation with shaking at room temperature for 1 h, the cells were pelleted at 1,500 g, washed with PBS, and incubated for 30 min with a 1:25 dilution of a fluorescein-conjugated goat anti-mouse IgG (BectonDickinson, Mountain View, CA). The cells were pelleted again, washed in PBS, resuspended in 0.2 ml PBS, and screened through a 43-Mm wire mesh. The cells were then immediately assayed for mean fluorescence in a FACStar flow cytometer (Becton-Dickinson). 2.5 X 104 cells were analyzed using a live gate placed on forward light scatter to exclude cell debris and dead cells. 300 MW of laser power and 488-nm excitation light were used. Fluorescence emission was collected through a 530/30 filter. Percent positive cells and mean fluorescence were determined using the Consort 40 software package (Becton-Dickinson). The lines were also analyzed using a control irrelevant antibody, the murine IgG2a myeloma protein RPC5 or the murine IgGl myeloma protein MOPC 21.
Preparation and hybridization of lung cancer cell line RNA. Total RNA was prepared from fresh cell cultures by the guanidium isothiocyanate/cesium chloride technique (19) , and quantitated by absorbance at 260 nm. Quantitation was confirmed by electrophoretically fractionating a sample on formaldehyde agarose gels, staining with ethidium bromide, and observing the intensities ofthe ribosomal RNA bands. 20 Mg of total RNA from each line was denatured and electrophoresed on a 1% agarose-formaldehyde gel (20) that had been modified by using 2.2 M formaldehyde in the gel and electrophoresing at 70 V for 5 h. The gels were transferred to nitrocellulose by capillary blotting and hybridization was performed using 50% formamide with the 32P-labeled probe and washing at 65°C. The c-myc probe consisted of a 1.5-kb Clal-EcoRI fragment encompassing the third exon of the c-myc gene (21) . The c-myc-containing plasmid, PMC 41 3RC, was obtained from Dr. S. Tronick (22) . The purified fragment was 32P-labeled by random priming (23) .
Cytokeratin extraction, electrophoresis, and Western blotting. Cytokeratins were extracted using a procedure modified from Wu and Rheinwald (24) . Cells were washed in PBS, pH 7.4, and placed into a Wheaton hand homogenizer containing 5 ml of 20 mM Tris-HCl, pH 7.4, 0.6 M KCI, 1% Triton X-100, and the protease inhibitors 1 mM PMSF, 1 mM EGTA, and 1 mM EDTA at 4°C. The insoluble fraction was pelleted by centrifugation at 10,000 g for 15 min, resuspended in the same buffer, recentrifuged, and resuspended in PBS. Gel electrophoresis and Western blotting of cytokeratins were as previously described (25) . Each lane contained the high-salt extract from 2 X 106 cells. Briefly, the blots were incubated with either AE-1, AE-2 or AE-3 primary antibodies in 3% normal goat serum (AE-l or AE-3, 1:200; AE-2, 1:100) for 16 h at 4°C. After washing, peroxidase-conjugated rabbit anti-mouse Ig (Cappel) was added, followed by 3-3-diaminobenzidine hydrochloride (Sigma Chemical Co.) 1 mg/ml with 0.05% H202 to develop the peroxidase reaction for 3-5 min before quenching with water.
Cytogenetic analysis. Cells were exposed to colcemid at a final concentration of 0.03 ug/ml for 30 min while the cells were in a logarithmic growth phase. Cells growing in a monolayer were washed briefly twice with HBSS (Grand Island Biological Co.) and exposed to 0.25% trypsin-EDTA (Grand Island Biological Co.) for 2-3 min. All cells were spun down at 1,200 g for 5 min. Hypotonic swelling, fixation, chromosome preparation, and Quinicrine banding procedures were the same as previously described (26). NSE assay. Cell pellets were homogenized in 10 vol of 10 mM Tris phosphate buffer containing 1 mM MgSO4. The homogenate was cen-trifuged and the soluble protein concentration of the supernatant was measured by the method of Lowry et al. (27) . The NSE assay was performed using a competitive radioimmunoassay protocol as previously described (4) . Statistical analysis. The significance of differences noted between groups of cell lines by various assays was analyzed using a KruskalWallis test.
Results
Growth characteristics and appearance of cells. The surfaceadherent and floating subpopulations of H446 cells were successfully segregated into relatively pure populations with a progressively decreasing tendency to revert to the original mixed pattern of growth. The surface-adherent and floating subcultures were maintained in culture for > 18 mo (Fig. 1) . The surface-adherent subline initially grew slowly, but became progressively more vigorous and fibroblastoid in appearance. The floating subline had a generation time of 42±4 h (SEM of duplicate cultures) and the surface-adherent subline had a generation time of 33±3 h. Each ofthe sublines cloned in soft agar with an approximate efficiency of 0.1% and these colonies were used to clone the sublines.
Expression ofNSE. The floating aggregate H446 cells consistently had higher expression of NSE than did the surfaceadherent H446 subline. When standardized for protein concentration, the H446 floating cells, in a representative assay, had 1,021 ng of NSE/mg of protein±48 ng/ml (SEM of quadruplicate cultures), compared with 379 ng of NSE/mg of protein± 19 ng/ml in the surface adherent H446 subline and 41 ng of NSE/mg protein±8 ng/ml in a NSCLC line NCI H522. The difference in NSE between the floating aggregate and surfaceadherent H446 sublines was significant with P < 0.025.
Cytogenetic analysis. Metaphase chromosomes from between 10 and 13 cells were analyzed for the floating, surfaceadherent, and parent H446 cell lines. The distribution of chromosome number was virtually the same between the three groups. All three cell lines had the derivative chromosome no. 3 with a deletion in the short arm which overlaps the characteristic deletion of 3p seen in SCLC cells (28) . Structural chromosome abnormalities found in common between floating, adherent, and parent lines included der(3), del(8)(p21), del(l l)(q13), der (18) the three lines included four no. 1 and four no. 7 chromosomes. There were no significant or consistent structural abnormalities observed in distinguishing among the floating, surface-adherent, or parental sublines of H446.
Reactivity ofSCLC cluster antigens. Flow cytometric analysis was performed using antibodies reactive with dominant SCLC surface antigens. Antibody UJ1 3A reacts with a 145,000-mol wt protein, found on SCLC and other neuroendocrine tumors but not NSCLC cells (16) . This protein has been recently identified on SCLC cells as the sialoglycoprotein NCAM (6) . The expression of this antigen was significantly greater in the floating subline than in the adherent subline (Table I) with P < 0.025. Very marked differences in reactivity were also seen with the AUA1 monoclonal antibody, which reacts with a 40,000-mol wt surface protein of unknown function, found on many epithelial tumors including SCLC (16) . The floating aggregate subline of H446 had three to four times the percentage of positive cells with AUA1 as the surface-adherent subline (Table I ). These differences in AUA 1 immunoreactivity were significant with P < 0.025. MAbs SWA 22 and SWA 20, reactive with different surface antigens on SCLC and a variety of neural and epithelial tumors, were equally positive with both surface-adherent and floating sublines of H446 (17) .
HNK-I reactivity. Radioimmunoassays, using the HNK-l MAb on fixed SCLC cells, consistently demonstrated that the floating H446 cells had at least five times the reactivity of the surface-adherent subline (Table II) . These differences were significant with P < 0.005. The NSCLC line, H125, used as a control, had the predicted low HNK-1 reactivity. HNK-1 has been demonstrated to react with NCAM and myelin-associated glycoprotein (13) . Control antibodies against invariant determinants of HLA and ,32-microglobulin did not discriminate between the adherent and floating sublines of H446 (Table II) although they demonstrated the previously described paucity of class I histocompatibility antigens in SCLC cells relative to NSCLC cells (29) .
To establish that the difference in surface antigen expression of NCAM-related determinants was related to the adherent phenotype, rather than simple clonal selection, we independently reselected surface-adherent and floating sublines from the parent H446 line. Multiple relatively pure cultures of floating and monolayer H446 cells were derived, without cloning, over a period of 3 mo. Repeat flow cytometric analy- (Table III) . The classic SCLC lines H209 and H 146, and the SCLC-v line N417, each of which forms floating aggregates in culture, were positive for each antibody (Table III ). The differences in both UJ 1 3A and HNK-1 immunoreactivity between the three floating aggregate cell lines and the three lines forming monolayer surfaceadherent cultures were highly significant, with P < 0.005 for each antibody. Keratin analysis. No significant differences were seen between surface-adherent and floating H446 cells in the pattern of intermediate filament immunostaining (Fig. 2) . Both sublines showed a pattern of reactivity typical of variant SCLC cells (25, 30) . The immunoblot results of floating and surfaceadherent H446 cells were identical with respect to the known keratin molecular weight species between 40,000 and 68,000. Some minor lower molecular weight bands in the surface-adherent subline were noted, which may or may not represent some proteolysis of the keratins.
Analysis ofc-myc expression. RNA significantly from the c-myc expression of the parent line (Fig. 3 ). (32) . By Western blotting, HNK-1 recognizes the 180-and 140-, but not the 120-kD band of NCAM isolated from adult mouse brain by immunoaffinity purification, using another MAb BSP-2 (13). The HNK-1 epitope appears to be a carbohydrate moiety, in that it is heat resistant, destroyed by periodate treatment, but resistant to pronase (13) . Immunoblot data on SCLC cells identify two groups of HNK-1-reactive plasma membrane glycoproteins of 80,000 and 130,000 mol wt (33) . SCLC cells also release a 100,000-mol wt glycoprotein reactive with HNK-1 into the spent medium of cultured cells (34) . A secreted form of NCAM has also been demonstrated in neural tissues (35) .
Our results indicate that HNK-1 is a second NCAM-directed MAb which is markedly less reactive with the surfaceadherent H446 subline relative to the floating subline. Our finding that the ratio of binding of cells from floating compared to surface-adherent H446 sublines is approximately 5, with both HNK-1 and UJ13A antibodies, suggests that these two antibodies recognize the same antigen on SCLC cells.
We have shown that two other unusual SCLC-v cell lines, which grow as surface-adherent cell lines and have low expression of neuroendocrine markers, do not react with UJ 13A or HNK-1. These findings generalize the association ofNCAM immunoreactivity with SCLC growth as floating aggregates. In addition, up to 12% of NSCLC cancers have features of neuroendocrine differentiation (31) . Cell lines established from these tumors are unusual for NSCLC in that the cells grow as floating aggregates and have been demonstrated to react with HNK-1 and another NCAM-directed MAb NKH 1 (36) . This observation further strengthens the association of NCAM immunoreactivity and the adhesive properties oflung cancer cells and suggests that NCAM expression closely correlates with other markers of neuroendocrine differentiation.
The greater UJ 13A and HNK-1 reactivity of floating H446 cells, compared to the H446 adherent cells is the first reported association between NCAM-related determinants and homophilic cell-cell adhesion between SCLC cells. The association is strengthened by other findings we have reported with SCLC-v cells incubated with retinoic acid (37) . These retinoid-treated cells have a marked phenotypic change with the loosely aggregated variant cells becoming much more tightly clustered spheroids. This increased cell-cell adhesion is associated with a marked increase in HNK-1 reactivity among the retinoid-treated cells compared with untreated control cells (37) .
Other factors beside the total amount of NCAM protein may be responsible for the different adhesive properties of the floating and adherent H446 cells. Polysialylation of NCAM has been demonstrated to markedly reduce the homophilic binding of neural cells (38) . Different NCAM isoforms, owing to alternative RNA splicing, could also potentially change the adhesive properties of the molecule (39) . We are currently investigating whether there are differences in sialylation of NCAM proteins between the H446 sublines. In addition, the SCLC lines that grow as adherent monolayers may have an altered interaction with laminin, fibronectin, or other basement membrane proteins, relative to the more common SCLC lines that grow as floating aggregates in vitro. SCLC cells have laminin receptors and bind to laminin in adherence assays (40) . However, the inability of most SCLC cells to form monolayer cultures may be related to their lack of detectable fibronectin receptors, and weak binding to fibronectin in vitro (41) .
Recent evidence, including keratin patterns, suggest that SCLC derives from an epithelial bronchial cell rather than from cells which have migrated from the neural crest (42) . Our finding that the adherent H446 cells retain a SCLC-v keratin pattern suggests that there is no increase in terminal differentiation in an epithelial direction of these surface-adherent cells despite the morphologic changes. It appears, instead, that the adherent H446 have not undergone the neuroendocrine differentiation characteristic of most SCLC cells. Neuroendocrine differentiation of bronchial cells in SCLC could explain the appearance of the surface adhesion molecule NCAM. There is evidence that NCAM is a functionally important molecule in cell-cell interactions and adhesion in the developing nervous system (43) . NCAM may potentially be important in the early metastasis characteristic of SCLC cells. It has already been demonstrated, for example, that the 20% of patients with NSCLC whose tumors were positive for NCAM had a significantly shorter survival than did NSCLC patients with tumors negative for NCAM immunoreactivity (7) . The adherent and floating sublines of H446, which we have developed, should be useful models to study the expression and modulation of NCAM in SCLC cells.
